<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Repligen Corporation

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Repligen’s corporate headquarters are in Waltham, MA (USA), with additional administrative and manufacturing operations in Marlborough, MA; Bridgewater, NJ; Rancho Dominguez, CA; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Tony J. Hunt
    • FOUNDED
      1981
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    BridgeBio Pharma, Inc.

    BridgeBio Pharma, Inc.

    BridgeBio finds, develops, and delivers breakthrough medicines for genetic disease...

    BridgeBio finds, develops, and delivers breakth...

    Filing Type:    PU
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    Dynavax Technologies Corporation

    Dynavax Technologies Corporation

    Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceuti...

    Dynavax Technologies Corporation (Nasdaq: DVAX)...

    Filing Type:    PU
    Oracle Health, Inc.

    Oracle Health, Inc.

    Oracle Health is developing a Digital Health Insertable (Under The Skin) Cardiac D...

    Oracle Health is developing a Digital Health In...

    Amount Raised:    $182,002.00
    Fundraising Status:    EC
    Filing Type:    CF
    Cerus Corporation

    Cerus Corporation

    Cerus Corporation is dedicated solely to safeguarding the world’s blood supply a...

    Cerus Corporation is dedicated solely to safegu...

    Filing Type:    PU
    Establishment Labs Holdings Inc.

    Establishment Labs Holdings Inc.

    Establishment Labs is a global medical technology company focused on improving pat...

    Establishment Labs is a global medical technolo...

    Filing Type:    PU
    InVivo Therapeutics Holdings Corp.

    InVivo Therapeutics Holdings Corp.

    Armed with cutting-edge technology and MIT science, experienced business and medic...

    Armed with cutting-edge technology and MIT scie...

    Filing Type:    PU
    Grifols, S.A.

    Grifols, S.A.

    Grifols is a global healthcare company founded in Barcelona in 1909 committed to i...

    Grifols is a global healthcare company founded ...

    Filing Type:    PU
    dna ID, Inc.

    dna ID, Inc.

    The DNA ID platform is a community marketplace for genomics research. The app allo...

    The DNA ID platform is a community marketplace ...

    Amount Raised:    $57,589.00
    Fundraising Status:    EC
    Filing Type:    CF
    CryoPort, Inc.

    CryoPort, Inc.

    Cryoport is the industry’s most trusted provider of cold chain logistics solutio...

    Cryoport is the industry’s most trusted provi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.